Lan Ji

Lan Ji is a Researcher in the Immunobiology Department at Yale School of Medicine, affiliated with the Chen Lab. Their research focuses on genomic analysis of brain tumors, particularly meningiomas and glioblastomas, with an emphasis on molecular subtyping, clinical outcomes, and racial disparities in tumor behavior. They also investigate environmental health impacts, including air pollution effects on birth outcomes and occupational exposures in military populations. Additional research interests include radiation therapy optimization, frailty assessment in neuro-oncology patients, and the societal impacts of the COVID-19 pandemic on STEM professionals.

Key contributions include developing imaging-based predictive models for glioblastoma genotypes and advancing understanding of meningioma molecular subgroups' clinical implications. Their work bridges translational research with population health, addressing both basic science and public health challenges.

Recent studies explore disparities in cancer treatment utilization (e.g., hypofractionated radiotherapy), opioid prescribing trends post-injury, and vitamin C's role in mitigating metal exposure risks during pregnancy.